JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B6810 RP 67580

Summary: tachykinin NK1 receptor antagonist

<43.86 mg/mL
A1063 Cytochrome P450 CYP1B1 (190-198) [Homo sapiens]

Summary: Sequence: H2N-FLDPRPLTV-OH

≥105.7 mg/mL
SL1016 3-Methoxytyramine-d4 HCl

Summary: A stable isotope deuterated compound of 3-Methoxytyramine HCl
A4138 Tofacitinib (CP-690550,Tasocitinib)
5 Citation

Target: JAK

Summary: Janus kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL
A4071 Fluorouracil (Adrucil)
12 Citation

Target: Thymidylate Synthase

Summary: Antitumor agent;inhibitor of thymidylate synthase

insoluble in EtOH; ≥10.04 mg/mL
A8203 Ritonavir

Summary: HIV protease inhibitor

≥26 mg/mL
A4121 SNS-314 Mesylate

Target: Aurora Kinases

Summary: Aurora A/B/C kinases inhibitor, potent and selective

≥26.35 mg/mL
A4011 ONX-0914 (PR-957)
13 Citation

Target: Proteasome

Summary: Immunoproteasome inhibitor,potent and selective

≥29.03 mg/mL
A4310 Rosiglitazone HCl

Summary: PPARγ agonist

≥39.4 mg/mL
A4334 Avanafil
1 Citation

Target: Phosphodiesterases (PDEs)

Summary: PDE5 inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.6 mg/mL